Ferrocene conjugated Os(ii) complex for photo-catalytic cancer therapy of triple-negative breast cancer cells†
Abstract
A novel ferrocene-conjugated bimetallic Os(II) photocatalyst (OsFe) showed micromolar photocatalytic anticancer activity against triple-negative breast cancer cells via NADH oxidation and caspase 3 activation under visible light.
- This article is part of the themed collection: Articles behind our 2025 journal covers